Dexcom Acquires Nutrisense and Redesigns Stelo CGM with AI-Powered Personal Coaching

Dexcom is doubling down on the wellness market with two major moves aimed at non-diabetics. The company announced its acquisition of Nutrisense, a startup focused on glucose monitoring for health optimization. Simultaneously, its over-the-counter CGM, Stelo, is receiving an FDA-cleared redesign featuring advanced “pattern recognition” and “proactive AI coaching.”

These updates are designed to combat the “data fatigue” often reported by long-term users. Instead of just providing a stream of blood sugar readings, the new system will offer personalized weekly and daily summaries. The AI component aims to translate complex biological data into actionable insights, helping users understand how their lifestyle choices impact their metabolic health.

By integrating Nutrisense’s expertise with Dexcom’s hardware, the company is positioning itself to lead the burgeoning field of preventative health tech. This shift signals a future where continuous monitoring is not just for managing chronic illness, but a standard tool for general health maintenance and performance.